G L Bakris

Summary

Affiliation: Rush-Presbyterian-St. Luke's Medical Center
Country: USA

Publications

  1. ncbi Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans
    G L Bakris
    Department of Medicine, Ochsner Clinic, New Orleans, LA, USA
    Hypertension 29:744-50. 1997
  2. ncbi Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI
    V Fonseca
    Tulane University, New Orleans, LA 70112, USA
    Diabet Med 24:759-63. 2007
  3. ncbi Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients
    G R Sheinfeld
    Department of Medicine, University of Illinois at Chicago Medical Center, USA
    Am J Hypertens 12:80S-85S. 1999
  4. ncbi Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study
    G L Bakris
    Hypertensive Diseases Unit, Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Kidney Int 73:1303-9. 2008
  5. ncbi beta-blocker use and diabetes symptom score: results from the GEMINI study
    J B McGill
    Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Diabetes Obes Metab 9:408-17. 2007
  6. ncbi Renal effects of calcium antagonists in diabetes mellitus. An overview of studies in animal models and in humans
    G L Bakris
    Section on Nephrology, Ochsner Clinic, New Orleans, LA 70121
    Am J Hypertens 4:487S-493S. 1991
  7. ncbi Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial
    G L Bakris
    Department of Medicine, Hypertension Center, University of Chicago Pritzker School of Medicine, Chicago, Illinois 60637, USA
    Kidney Int 72:879-85. 2007
  8. ncbi Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program
    P A McCullough
    Department of Medicine, Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Intern Med J 40:833-41. 2010

Detail Information

Publications8

  1. ncbi Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans
    G L Bakris
    Department of Medicine, Ochsner Clinic, New Orleans, LA, USA
    Hypertension 29:744-50. 1997
    ....
  2. ncbi Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI
    V Fonseca
    Tulane University, New Orleans, LA 70112, USA
    Diabet Med 24:759-63. 2007
    ..To determine whether the beneficial effects of carvedilol on insulin resistance (IR) are affected by the concomitant use of insulin sensitizers [thiazolidinediones (TZDs) and metformin]...
  3. ncbi Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients
    G R Sheinfeld
    Department of Medicine, University of Illinois at Chicago Medical Center, USA
    Am J Hypertens 12:80S-85S. 1999
    ..This paper reviews the importance of aggressive blood pressure control in diabetic patients and the clinical trials supporting the use of combination ACE inhibitor/calcium antagonist therapy in the diabetic patient population...
  4. ncbi Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study
    G L Bakris
    Hypertensive Diseases Unit, Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Kidney Int 73:1303-9. 2008
    ..The dissociation between reductions in blood pressure and albuminuria may be related to factors other than blood pressure...
  5. ncbi beta-blocker use and diabetes symptom score: results from the GEMINI study
    J B McGill
    Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Diabetes Obes Metab 9:408-17. 2007
    ..In this paper, we report the results of a prespecified secondary analysis of GEMINI that sought to determine the effect of these two beta-blockers on commonly reported symptoms...
  6. ncbi Renal effects of calcium antagonists in diabetes mellitus. An overview of studies in animal models and in humans
    G L Bakris
    Section on Nephrology, Ochsner Clinic, New Orleans, LA 70121
    Am J Hypertens 4:487S-493S. 1991
    ..abstract truncated at 250 words)..
  7. ncbi Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial
    G L Bakris
    Department of Medicine, Hypertension Center, University of Chicago Pritzker School of Medicine, Chicago, Illinois 60637, USA
    Kidney Int 72:879-85. 2007
    ..Our results suggest that patients with cardiovascular risk and relatively low albumin excretion rates in early-stage disease may only require monotherapy with renin-angiotensin-aldosterone blocking agents...
  8. ncbi Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program
    P A McCullough
    Department of Medicine, Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Intern Med J 40:833-41. 2010
    ..Coronary artery disease (CAD) identifies the need for intensive treatment of risk factors among individuals with chronic kidney disease (CKD), a high-risk, complex cardiovascular risk state...